29.01.2020 • News

Catalent Appoints Ricci Whitlow as President of Clinical Supply Services

Catalent has appointed Ricci Whitlow as president of its Clinical Supply...
Catalent has appointed Ricci Whitlow as president of its Clinical Supply Services business unit. Source: Catalent

Catalent has appointed Ricci Whitlow as president of its Clinical Supply Services business unit. She succeeds Paul Hegwood, who will retire in March 2020.

Whitlow has over 25 years’ experience in the pharmaceutical biologics and medical device industry, and she rejoins Catalent after two-and-a-half years, having previously held the position of vice president Operations. In her most recent position, she served as senior vice president of Technical and Corporate Operations at OptiNose.

During her career, she has also worked for LifeCell and Johnson & Johnson. Whitlow holds a master’s degree in business administration from the TRIUM program of NYU Stern School of Business, London School of Economics and HEC Paris; as well as a B.Sc. in Industrial Engineering from Texas A&M University.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.